Cargando…
ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma
OBJECTIVE: ARID1A has been discovered as a potential cancer biomarker. But its role in hepatocellular carcinoma (HCC) is subject to considerable dispute. METHODS: The relationship between ARID1A and clinical factors was investigated. Clinicopathological variables related to overall survival in HCC s...
Autores principales: | Feng, Yuanyuan, Tang, Xinfang, Li, Changcheng, Su, Ying, Wang, Xiaoyu, Li, Ning, Zhang, Anna, Jiang, Feng, Wu, Chuyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752298/ https://www.ncbi.nlm.nih.gov/pubmed/35028302 http://dx.doi.org/10.1155/2022/3163955 |
Ejemplares similares
-
PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
por: Liu, Wen-Feng, et al.
Publicado: (2022) -
AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021) -
BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022) -
ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022) -
LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)